Camrelizumab Combined With CRT for Treatment of Patients With Local Recurrence of Esophageal Cancer
Clinical trial NCT04390945 · UNKNOWN
Trial details
- NCT number
- NCT04390945
- Sponsor
- The First Affiliated Hospital of Henan University of Science and Technology
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2023-10-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.